10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents
Open Access
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJACC, 2011
- The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating conceptsBiomaterials, 2009
- A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stentsEuropean Heart Journal, 2008
- Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosisEuropean Heart Journal, 2008
- Vascular Responses to Drug Eluting StentsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent CoatingArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994